On April 9th, Rep. Chris Smith sent a letter to Health and Human Services (HHS) Secretary Alex Azar and the National Institute for Allergies and Infectious Disease (NIAID) Director, Dr. Anthony Fauci, thanking them for their tireless efforts to address the Coronavirus outbreak as well as expressing his concerns about Lyme disease sufferers and their […]
Search Results for: COVID
Conference/WG Meeting Clips/Neuropsychiatric Lyme/COVID-19/House Lyme Caucus/Monies for Researchers/WG Meeting Summary/Tickmojis
Important Announcement: The Lyme Disease Association (LDA) and Columbia University have jointly announced our thoughtful but reluctant decision to postpone our annual fall 2020 CME Lyme & Other Tick-Borne Diseases Conference due to the worldwide COVID-19 (SARS-CoV-2) health emergency . The safety and well-being of everyone are our primary concerns, and we hope everyone remains safe.
Below is a compilation of Covid-19 information from scientific sources compiled by Dr. Robert Bransfield, MD that the LDA has permission to post. Dr. Bransfield thanks contributors to this project: members of ILADS, Microbes and Mental Illness listserv, and Psychopharmacology listserv. Disclaimer: The LDA is providing this piece for informational purposes only. The opinions expressed […]
Director, Lyme Disease Research Center Associate Professor of Medicine, Johns Hopkins University School of Medicine Baltimore, MD hopkinslyme.org Long Haulers: Lessons from Lyme Disease, ME/CFS, and COVID-19 Dr. Aucott is an Associate Professor of Medicine in the Division of Rheumatology at Johns Hopkins University Medical School and the Director of the Johns Hopkins Lyme Disease […]
LDA President’s Blog – Why Patients Need Government Investigation into Lyme’s Origins & Any Biowarfare Experiments
HISTORY-Forty-six years after a mother alerted public health about an unknown disease affecting her Connecticut neighborhood, patients still await answers about Lyme disease and help from the federal government− little has been forthcoming. It’s been 37 years since I first saw Lyme as a board of education member and 29 years since I first contacted […]
10:00 – 10:25 Patricia V. Smith, BA (Conference Chair) President, Lyme Disease Association, Inc. Jackson, NJ Welcome, Remarks/Brief Overview of LDA, Lyme & Tick-Borne Diseases / Fallon Intro 10:25 – 11:05 John Aucott, MD / Keynote Associate Professor of Medicine Director, Johns Hopkins Medicine Lyme Disease Research Center Baltimore, MD Long Haulers: Lessons from Lyme […]
The Lyme Disease Association announces that the House voted this week to pass a number of amendments to the NDAA, National Defense Authorization Act, including a Congressman Chris Smith amendment – The Comptroller General of the United States shall conduct a review of whether the Department of Defense experimented with ticks, other insects, airborne releases […]
CONFERENCE COMPLETED The Lyme Disease Association Inc. and Columbia University Vagelos College of Physicians & Surgeons jointly provided the 21st annual CME scientific conference, Lyme & Other Tick-Borne Diseases: Research for a Cure, virtually, on October 2, 2021. This conference is designed to meet the high standards for continuing medical education credits for medical & health professionals and researchers. It was also open to the general public (adults only). Limited number of scholarships were available for certain medical students, researchers, recent medical professionals.The conference was sponsored by the Stephen & Alexandra Cohen Foundation and IGeneX Inc.
In a letter to physicians, the Maryland Department of Health (MDH) warns doctors to pay attention to Lyme which is the most frequently diagnosed tick-borne disease (TBD) in Maryland residents (1400 cases 2019). The MDH also cautions them to report other TBDs, which it specifically names. The letter also points out the similarities of Lyme […]
Elizabeth L. Maloney, MD, reviews the US trial evidence on EM rashes, problems of the IDSA recommendations considering that evidence, and provides evidence-based patient-centered strategies for managing patients with EM. “The EM rash is the hallmark finding of early disease,” along with other symptoms. “In light of the physical and financial costs, identifying and promoting highly effective therapeutic interventions for US patients with erythema migrans (EM) rashes that return them to their pre-infection health status should be a priority.”